Back
ESC2025 Premium Access

Unique amino acid profile and prognostic significance of the Fischer ratio in end-stage kidney disease patients with cardiovascular disease

Session: Renal and cardiovascular disease (1)
Topic: Renal Failure and Cardiovascular Disease
Speaker: Assistant Professor K. Moribayashi (Miyazaki, JP)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Assistant Professor Kohei Moribayashi

University of Miyazaki, Miyazaki (Japan)
0 follower

5 more presentations in this session

Correlation between renal function level and ventricular remodeling, and mechanistic study of slc10a6-mediated ventricular remodeling after chronic kidney disease

Speaker: Mr W. Zhang (Guangzhou, CN)

Access
Abstract
Slides
Like
Thumbnail

Complement Factor D is an independent prognostic marker in patients with chronic kidney disease in the UK-Biobank

Speaker: Doctor M. Berger (Aachen, DE)

Access
Abstract
Slides
Video
Like
Thumbnail

Canagliflozin in patients with type 2 Diabetes and CKD experiencing deterioration in eGFR to <20 ml/min/1.73m2 in the CREDENCE Trial

Speaker: Doctor S. Chatur (Boston, US)

Access
Abstract
Slides
Like
Thumbnail

Understanding arteriovenous fistula physiology: preoperative and early postoperative effects on left ventricular myocardial work

Speaker: Doctor A. Safak Arslanhan (Istanbul, TR)

Access
Abstract
Slides
Video
Like
Thumbnail

Impact of statin therapy on mortality in chronic kidney disease patients without atherosclerotic cardiovascular disease: insights from american and chinese cohorts (MIMIC-IV and CIN-II Databases)

Speaker: Mr W. Zhang (Guangzhou, CN)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Renal and cardiovascular disease (1)

Speakers: Assistant Professor K. Moribayashi, Mr W. Zhang, Doctor M. Berger, Doctor S. Chatur, Doctor A. Safak Arslanhan...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources